News
1d
MedPage Today on MSNGLP-1 Therapy Helps Amplify Bariatric Surgery Weight Loss, But Timing MattersIn 568 patients who underwent bariatric surgery, those who also used a GLP-1 receptor agonist during the preoperative and ...
A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...
Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...
Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body weight ...
Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body ...
Researchers say GLP-1 medicines might be able to help with migraines.
A large network meta-analysis ranked eight GLP-1 receptor agonists for glycemic, weight, and safety outcomes in adults with ...
Subsequent hospitalization rates were lower among patients with type 2 diabetes who received liraglutide compared with glimepiride.
An Ozempic-like drug prescribed for diabetes has been found to reduce the frequency of debilitating migraine. Researchers say ...
For adults with obesity and migraine, liraglutide reduces migraine burden, with reductions in mean monthly headache days.
A current weight-loss and diabetes drug has become a surprise candidate for migraine treatment, with a new pilot study ...
A new study reveals that the popular diabetes and weight-loss drug Ozempic might hold the key to relieving chronic migraines, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results